CYFRA 21-1 levels (ng·ml -1 ) in benign lung disease | Download Table
Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease Chen F, Li J, Qi X, Qi J - J Can Res Ther
A Novel Immunoassay for the Quantization of CYFRA 21–1 in Human Serum - He - 2013 - Journal of Clinical Laboratory Analysis - Wiley Online Library
PDF) CYFRA 21-1 as a tumour marker for bronchogenic carcinoma
Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer - Yoshimura - Translational Lung Cancer Research
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - Journal of Thoracic Oncology
Epithelial tumor markers
Ultrasensitive label-free detection for lung cancer CYFRA 21-1 DNA based on ring-opening polymerization - ScienceDirect
Sigma Diagnostics | CYFRA 21-1
IVD Antibody Development Services for CYFRA21-1 Marker - Creative Biolabs
Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free
Cyfra 21-1 EIA July 2009 (2).pdf - Fujirebio Diagnostics, Inc.
Cyfra 21-1 as a Serum Tumor Marker for Follow-up of Patients with Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | Anticancer Research
Relationship of CYFRA 21-1 to the histo- logical type of NSCLC and the... | Download Scientific Diagram
Table 1 from Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | Semantic Scholar
Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer - Chemical Communications (RSC Publishing)
Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer
researchopenworld.com
Cyfra 21-1 Blood test | Blood Tests in London
Cyfra 21-1 as a Biologic Marker of Non-small Cell Lung Cancer
Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients
Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer - Yoshimura - Translational Lung Cancer Research
Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer - Chemical Communications (RSC Publishing)
Sigma Diagnostics | CYFRA 21-1
Elevation of cytokeratin 19 fragment (CYFRA 21-1) in serum of patients with radiation pneumonitis: possible marker of epithelial cell damage - Respiratory Medicine
Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers - Crosbie - Translational Lung Cancer Research
CYFRA 21-1 Serum Analysis in Patients with Esophageal Cancer | Clinical Cancer Research
Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis - ScienceDirect
